Drug Trials Snapshot - GEMTESA

A new DRUG TRIALS SNAPSHOT is now available. GEMTESA is used treat the following symptoms due to a condition called overactive bladder (OAB): a strong need to urinate with leaking or wetting accidents, the need to urinate right away, and the need to urinate often. GEMTESA is a tablet taken my mouth once a day.   See more Drug Trials Snapshots or contact us with questions at Snapshots@fda.hhs.gov     Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA